ArticleBMC neurology2025
Utility of transorbital ultrasound to assess disability and axonal loss in multiple sclerosis.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn multiple sclerosis (MS), axonal damage plays a significant role in contributing to disability. This study assesses the diagnostic accuracy and use of transorbital sonography (TOS) as a surrogate for axonal loss by measuring the optic nerve diameter (OND) and optic nerve sheath diameter (ONSD). METHODOLOGY: It was a cross-sectional study in the Neurology Department, Government Medical College, Thiruvananthapuram. MS patients were enrolled, and expanded disability status scale (EDSS) scores assessed their disability. Disability was defined as EDSS > 2. OND and ONSD were measured using TOS. The retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) were measured using optical coherence tomography (OCT). We constructed receiver operating characteristics curve using RNFL as gold standard to detect axonal loss and disability. The sensitivity and specificity of GCC, OND and ONSD were independently calculated from the ROC curve which could predict the disability.
resultThe EDSS scores varied from 0 to 5.5. The disabled group had 10.3 ± 1.9 μm thinner RNFL (p < 0.001), 40.8 ± 15.5 μm thinner GCC (p 0.0038) as compared to the nondisabled group. OND was 3.8 ± 0.6 mm thinner (p 0.037) and ONSD was 4.6 ± 0.6 mm thinner (p 0.010) as compared to the control group. OND and RNFL were independent predictors for disability; the optimum cut-off to detect disability was 4.35mmfor OND and 12 μm for RNFL; the optimum cut-off to detect axonal loss was 4.43 mm for OND.
conclusionWe found an optimum OND and RNFL cutoff to predict disability and an optimum cut-off for OND to predict axonal loss. TOS could be an economical and accurate alternative to OCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.